ViTrox Corp’s outlook has dimmed amid growing concerns over looming US tariffs, prompting more analysts to issue ‘sell’ calls despite the company’s latest earnings meeting expectations.
Key Points:
Analyst Downgrade: Hong Leong Investment Bank (HLIB) downgraded the stock after Q2 results, citing valuation risks and tariff uncertainty.
Current Ratings: 5 ‘Sell’, 3 ‘Hold’, 4 ‘Buy’.
Average Target Price: RM3.21 — implying a potential 13% downside from Friday’s RM3.72 close.
Valuation Concerns:
Shares have rebounded 60% from April lows, but now trade at ~49x forward earnings.
HLIB warns the valuation “appears stretched” given demand risks from possible US tariffs.
US Tariff Risk:
US President Donald Trump has hinted at 15% to 50% reciprocal tariffs, with an Aug 1 deadline.
A blanket 25% tariff on Malaysian goods is being considered, alongside sector-specific tariffs on semiconductors.
Tax Incentive Uncertainty:
ViTrox’s pioneer status tax incentive expired in June 2025.
HLIB flagged risk of non-renewal, while CIMB remains optimistic a new scheme will be approved by year-end, calling it a key re-rating catalyst.
Earnings Snapshot (2QFY2025):
Net Profit: RM28.13M (flat YoY)
Revenue: RM183.04M (+30% YoY)
Growth driven by automated board inspection and machine vision systems, offset by a higher tax provision.
Conclusion & Takeaways:
US tariff uncertainty is the biggest overhang, with potential to hit both demand and margins.
Valuation is at a premium, leaving little buffer against negative developments.
Renewal of tax incentives could help sentiment, but for now, analysts are leaning bearish.
Bottom line: ViTrox faces a critical few months ahead, with both tariffs and tax policy outcomes likely to determine whether the stock maintains its rally—or faces a pullback.
Comments
Post a Comment